All In Biotech

Drug Trial Radar · NCT06840691

A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations

A Randomized, Open-lable, Single-dose, 3-sequence, 3-period Crossover Bioequivalence Study of Two Different PEG-rhGH (2mg/mL)Preparations in Chinese Healthy Adults

Last checked: Nov 20, 2026Latest source record: Feb 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

87

Planned (sponsor's estimate)

Start

May 2025

Primary completion

May 2025

Study completion Sep 2025

Sponsor

Sponsor type
Industry
First posted
Feb 21, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Other
FDA-regulated drug
No
Who can join
Male only, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate whether PEG-rhGH with new preparation is bioequivalent to PEG-rhGH with present preparation.

Conditions

  • Pediatric Growth Hormone Deficiency (PGHD)

Interventions

  • PEG-rhGH with new preparation (T)Drug

    A single subcutaneous injection of PEG-rhGH with new preparation

  • PEG-rhGH with present preparation (T)Drug

    A single subcutaneous injection of PEG-rhGH with present preparation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pharmacokinetics (Peak Plasma Concentration (Cmax) ) of PEG-rhGH with present and new preparationTime frame: 0 hours -408 hours post-administration
  2. Pharmacokinetics (Area under the concentration-time curve from time zero to time infinity (AUC0-inf)) of PEG-rhGH with present and new preparationTime frame: 0 hours -408 hours post-administration
  3. Pharmacokinetics (Area under the concentration-time curve from time zero to the time of the last quantifiable (AUC0- last )) of PEG-rhGH with present and new preparationTime frame: 0 hours -408 hours post-administration

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Chengdu Xinhua Hospital

    Chengdu, Sichuan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.